These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22364298)
1. Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment. Milutinović A; Zorc-Pleskovič R Bosn J Basic Med Sci; 2012 Feb; 12(1):15-9. PubMed ID: 22364298 [TBL] [Abstract][Full Text] [Related]
2. Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid. Milutinović A Bosn J Basic Med Sci; 2016 Nov; 16(4):261-267. PubMed ID: 27289244 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. Gabrielson KL; Hogue BA; Bohr VA; Cardounel AJ; Nakajima W; Kofler J; Zweier JL; Rodriguez ER; Martin LJ; de Souza-Pinto NC; Bressler J Am J Pathol; 2001 Oct; 159(4):1507-20. PubMed ID: 11583977 [TBL] [Abstract][Full Text] [Related]
4. 3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease. Miller PJ; Zaborszky L Exp Neurol; 1997 Jul; 146(1):212-29. PubMed ID: 9225755 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats. Khan A; Jamwal S; Bijjem KR; Prakash A; Kumar P Neuroscience; 2015 Feb; 287():66-77. PubMed ID: 25536048 [TBL] [Abstract][Full Text] [Related]
6. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia. Page KJ; Besret L; Jain M; Monaghan EM; Dunnett SB; Everitt BJ Exp Brain Res; 2000 Jan; 130(2):142-50. PubMed ID: 10672467 [TBL] [Abstract][Full Text] [Related]
7. 3-Nitropropionic acid-induced changes in the expression of metabolic and astrocyte mRNAs. Page KJ; Dunnett SB; Everitt BJ Neuroreport; 1998 Aug; 9(12):2881-6. PubMed ID: 9760139 [TBL] [Abstract][Full Text] [Related]
8. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration. Hariharan A; Shetty S; Shirole T; Jagtap AG Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565 [TBL] [Abstract][Full Text] [Related]
9. Folic acid increases levels of GHS in brain of rats with oxidative stress induced with 3-nitropropionic acid. Calderón Guzmán D; Osnaya Brizuela N; Ortiz Herrera M; Juárez Olguín H; Valenzuela Peraza A; Hernández García E; Barragán Mejía G Arch Physiol Biochem; 2020 Feb; 126(1):1-6. PubMed ID: 30269600 [No Abstract] [Full Text] [Related]
10. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β. Wu W; Liu X; Han L Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226 [TBL] [Abstract][Full Text] [Related]
11. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Kumar P; Kalonia H; Kumar A Life Sci; 2009 Nov; 85(19-20):711-8. PubMed ID: 19822156 [TBL] [Abstract][Full Text] [Related]
12. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157 [TBL] [Abstract][Full Text] [Related]
13. Cardiotoxic injury caused by chronic administration of microcystin-YR. Suput D; Zorc-Pleskovic R; Petrovic D; Milutinović A Folia Biol (Praha); 2010; 56(1):14-8. PubMed ID: 20163777 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390 [TBL] [Abstract][Full Text] [Related]
15. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats. Suganya SN; Sumathi T Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694 [TBL] [Abstract][Full Text] [Related]
16. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864 [TBL] [Abstract][Full Text] [Related]
17. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Kumar P; Padi SS; Naidu PS; Kumar A Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats. Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362 [TBL] [Abstract][Full Text] [Related]
19. The effect of 3-nitropropionic acid on behavioral dysfunction, neuron loss and gliosis in the brain of adult male rats: The case of prefrontal cortex, hippocampus and the cerebellum. Torabi A; Joneidi M; Mohammadzadeh I; Abdollahifar MA; Khatmi A; Ezi S; Moghaddam MH; Rafiei R; Kahrizirad F; Norozian M; Aliaghaei A Toxicon; 2020 Aug; 183():44-50. PubMed ID: 32464148 [TBL] [Abstract][Full Text] [Related]
20. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Mahdy HM; Tadros MG; Mohamed MR; Karim AM; Khalifa AE Neurochem Int; 2011 Nov; 59(6):770-8. PubMed ID: 21827809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]